Synthesis 2016; 48(07): 1019-1028
DOI: 10.1055/s-0035-1561339
paper
© Georg Thieme Verlag Stuttgart · New York

N-Monoacylation of Sulfonimidamides

Yantao Chen*
AstraZeneca Innovative Medicines Cardiovascular and Metabolic Diseases, 431 83 Mölndal, Sweden   Email: yantao.chen@astrazeneca.com
› Author Affiliations
Further Information

Publication History

Received: 02 November 2015

Accepted after revision: 07 January 2016

Publication Date:
26 January 2016 (online)


Abstract

N-Monoacylated sulfonimidamides, the aza analogue of N-acylsulfonamides which are a common motif in drug discovery, were exclusively synthesized by using a 1:1-premixed mixture of an acyl chloride and pyridazine as the acylating agent, while diacylation exclusively occurred when N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide (EDC) was used as the coupling agent. The monoacylation is fast, easy to operate, and applicable to both aromatic and aliphatic acyl chlorides to give the corresponding products in moderate or high overall yields. A two-step N,N′-diacylated product exemplifies that the sulfonimidamide moiety provides one more handle than its sulfonamide isostere. This stepwise functionalization approach can be used to fine-tune the desired properties of compounds in medicinal chemistry.

Supporting Information